In modern blood banking, quality control of blood products ensures the timely availability of a blood component of high-quality yield with maximum efficacy and minimal risk to potential recipients. A prospective cross-sectional study was carried out at Mansoura University Hospital Blood Bank (MUHBB) aiming to assess the internal quality control (IQC) of 300 units of each blood components, red blood cell concentrates (RBCs), fresh frozen plasma (FFP), and platelet concentrates (PCs), and to explore their compliance with The Egyptian National Blood Transfusion Services (NBTS ),The American Association of Blood Banks (AABB), and Council of Europe (CE) standard criteria. IQC of different blood products was accepted if > 90% of units were fulfilled the standard requirements. The results of our study show that the total compliance of RBCs was 93.3% according to NBTS and CE standards and 96% as regards AABB standards. The total compliance of FFP was 94.0% according to NBTS and CE standards and 96.0% as regards AABB standards. While the total compliance of PCs was 96.0% according to NBTS and AABB standards and 93.3% as regards CE standards. Continuous improvement is recommended to decrease the percentage of noncompliance in the QC parameters included in our study and to uplift the blood transfusion practices.
Shahin et al. (2025) studied this question.